Jake G.
About Jake G.
Jake G. is the Director of Product at Ophelia, where he focuses on developing technology solutions to improve addiction treatment. He holds degrees in Computer Science and Statistics from the University of Pennsylvania and has previously worked as a software engineer at various companies, including Axonius and Bridgewater Associates.
Current Role at Ophelia
Jake G. serves as the Director of Product at Ophelia, a position he has held since 2022. In this role, he focuses on developing innovative products that address the challenges associated with opioid use disorder treatment. His work aims to enhance accessibility and affordability in addiction treatment, reflecting his commitment to leveraging technology for improved healthcare outcomes.
Previous Experience at Ophelia
Prior to his current role, Jake G. was a Founding Engineer at Ophelia from 2020 to 2022. During his tenure, he contributed to the foundational development of the company's technology and products, which are designed to support individuals facing addiction challenges.
Educational Background
Jake G. studied at the University of Pennsylvania, where he completed the Jerome Fisher M&T Program. He earned a Bachelor of Engineering in Computer Science from Penn Engineering and a Bachelor of Science in Statistics from The Wharton School. His educational background provides a strong foundation for his work in technology and product development.
Work Experience Prior to Ophelia
Before joining Ophelia, Jake G. held several engineering positions. He worked as a Software Engineer at Axonius from 2018 to 2019 in Tel Aviv, Israel, and at Bridgewater Associates for 11 months in Westport, Connecticut, in 2019. Additionally, he was a Founding Engineer at Forage from 2019 to 2020 in Philadelphia, Pennsylvania.
Funding Contributions
Jake G. played a key role in securing funding for Ophelia from notable investors, including Tiger Global, Menlo, General Catalyst, Refactor, and Y Combinator. His efforts in this area have been significant in supporting the company's mission to improve healthcare outcomes in addiction treatment.